Provided by Tiger Trade Technology Pte. Ltd.

Bruker

38.94
-0.5400-1.37%
Post-market: 38.940.00000.00%18:51 EDT
Volume:1.51M
Turnover:59.07M
Market Cap:5.92B
PE:-259.60
High:39.71
Open:39.48
Low:38.67
Close:39.48
52wk High:56.22
52wk Low:28.53
Shares:151.94M
Float Shares:103.15M
Volume Ratio:0.99
T/O Rate:1.47%
Dividend:0.20
Dividend Rate:0.51%
EPS(TTM):-0.1500
EPS(LYR):-0.1500
ROE:-0.38%
ROA:2.90%
PB:2.41
PE(LYR):-259.60

Loading ...

BRIEF-Bruker Q4 Adjusted EPS USD 0.59 Vs. IBES Estimate USD 0.65

Reuters
·
Feb 12

Bruker Q4 Adjusted EPS USD 0.59 VS. Ibes Estimate USD 0.65

THOMSON REUTERS
·
Feb 12

Bruker Outlook FY Adjusted EPS USD 2.1-2.15

THOMSON REUTERS
·
Feb 12

Bruker Q4 Operating Expenses USD 372.9 Million

THOMSON REUTERS
·
Feb 12

Bruker Q4 Net Income USD 29.2 Million

THOMSON REUTERS
·
Feb 12

Bruker Q4 Gross Profit USD 449.2 Million

THOMSON REUTERS
·
Feb 12

How Bruker’s AI Self-Driving Lab Push and New Bioparticle Tool Could Impact Bruker (BRKR) Investors

Simply Wall St.
·
Feb 12

Bruker announces launch of iNTApharma

TIPRANKS
·
Feb 09

Chemspeed und SciY, Divisionen der Bruker Corporation, stellen gemeinsame Self-Driving Lab Plattform vor

Reuters
·
Feb 09

Bruker stellt neues iNTApharma-System zur label-freien Nanopartikel-Analyse vor

Reuters
·
Feb 09

Bruker zahlt Quartalsdividende auf Vorzugsaktien

Reuters
·
Feb 06

Bruker Corporation to Announce Fourth Quarter and Fiscal Year 2025 Financial Results

Reuters
·
Feb 05

Barclays Keeps Their Buy Rating on Bruker (BRKR)

TIPRANKS
·
Feb 02

Bruker Is Maintained at Buy by Guggenheim

Dow Jones
·
Jan 27

Bruker EVP Mark Munch Reports Disposal of Common Shares

Reuters
·
Jan 17

Bruker Is Maintained at Neutral by Citigroup

Dow Jones
·
Jan 17

Bruker price target raised to $53 from $40 at Citi

TIPRANKS
·
Jan 16

Bruker: Solid Q4 Momentum and Reaffirmed 2026 Targets Underpin Buy Rating and Upside Potential

TIPRANKS
·
Jan 13

GUIDANCE: (BRKR) Bruker Expects Q4 Revenue Range $965M - $970M, vs. FactSet Est of $958.3M

MT Newswires Live
·
Jan 13

Bruker clarifies regulatory filing status in recent 8-K

TIPRANKS
·
Jan 13